NHSA Releases 2026 NRDL Update Adding 107 Drugs Including Million‑Yuan CAR‑T Therapies – Ninth List Adjustment Since the Agency’s Establishment
China's National Healthcare Security Administration (NHSA) released the National Drug List for Basic Medical Insurance, Maternity Insurance, and Work‑Related Injury Insurance (NRDL) and the Commercial Health Insurance Innovative Drug List…
BeOne Medicines Opens Shanghai Innovation Center – A 55,855 m² Self‑Built R&D Hub Purpose‑Built for AI‑Driven Antibody Discovery and Next‑Generation ADCs
BeOne Medicines Ltd. (NASDAQ: ONC; HKG: 6160; SHA: 688235) announced the official opening of its Shanghai Innovation Center, a wholly self‑built research and development campus that will serve as one of the global biotech's key hubs for early‑stage drug discovery.…
Where biopharma's biggest deals take shape!
Merck and Isomorphic Labs Forge AI Drug Discovery Collaboration – Oncology Small‑Molecule Focus
Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, and Isomorphic Labs — the AI‑first drug design and development company under Alphabet Inc. (NASDAQ:…
China Issues Joint Notice to Accelerate Hospital Adoption of Innovative Drugs – NRDL and Commercial Insurance Lists Get Fast-Track Deployment
The General Office of the National Health Commission (NHC), the Office of the National Healthcare Security Administration (NHSA), the General Office of the National Administration of Traditional Chinese Medicine, and…
